pyrroles has been researched along with Chondrosarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Astolfi, A; Casali, PG; Colombo, C; Conca, E; Crippa, F; Dagrada, GP; Dei Tos, AP; Gronchi, A; Indio, V; Maestro, R; Morosi, C; Negri, T; Pantaleo, MA; Pilotti, S; Stacchiotti, S; Tazzari, M; Toffolatti, L | 1 |
| Bovée, JV; Briaire-de Bruijn, I; Cleton-Jansen, AM; Cleven, AH; Danen, EH; De Jong, Y; Fletcher, JA; Peterse, EF | 1 |
| Abdollahi, A; Bertl, E; Ewerbeck, V; Gebhard, MM; Huber, PE; Klenke, FM; Sckell, A | 1 |
3 other study(ies) available for pyrroles and Chondrosarcoma
| Article | Year |
|---|---|
Activity of sunitinib in extraskeletal myxoid chondrosarcoma.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Bone Neoplasms; Calmodulin-Binding Proteins; Chondrosarcoma; DNA-Binding Proteins; Drug Resistance, Neoplasm; Female; fms-Like Tyrosine Kinase 3; Gene Rearrangement; Genotype; Humans; Indoles; Male; Middle Aged; Neoplasms, Connective and Soft Tissue; Phenotype; Proto-Oncogene Proteins c-kit; Proto-Oncogene Proteins c-ret; Pyrroles; Receptor, Platelet-Derived Growth Factor beta; Receptors, Steroid; Receptors, Thyroid Hormone; RNA-Binding Protein EWS; RNA-Binding Proteins; Sunitinib; TATA-Binding Protein Associated Factors; Treatment Outcome; Vascular Endothelial Growth Factor Receptor-2 | 2014 |
No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Chondrosarcoma; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Molecular Targeted Therapy; Pyrimidines; Pyrroles; Receptor, IGF Type 1; Receptors, Somatomedin; Signal Transduction | 2016 |
Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth via antiangiogenesis in vivo.
Topics: Angiogenesis Inhibitors; Animals; Chondrosarcoma; Disease Models, Animal; Indoles; Injections, Subcutaneous; Male; Mice; Mice, SCID; Microcirculation; Oxindoles; Propionates; Pyrroles; Treatment Outcome | 2007 |